Schreibman I R, Bejarano P, Martinez E J, Regev A
Division of Hepatology, University of Miami, Leonard M. Miller School of Medicine, Miami, Florida 33136, USA.
Transplant Proc. 2006 Nov;38(9):3140-3. doi: 10.1016/j.transproceed.2006.08.095.
Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.
肝细胞癌(HCC)在肝移植(OLT)后10%至60%的患者中复发,并与死亡率增加相关。OLT后复发的平均时间为1至2年,从诊断时起的中位生存期约为1年。我们报告一例69岁男性患者,因丙型肝炎病毒相关性肝硬化合并HCC接受OLT,OLT后6.5年被诊断为复发性HCC。初始肿瘤和复发性肿瘤的活检显示为高分化HCC,伴有透明细胞模式灶。尽管肿瘤负荷广泛,但诊断后32个月患者仍存活且无症状。他在OLT后9年9个月、复发检测后3年2个月死亡。总之,HCC可能在OLT后6年以上复发,且可能呈现惰性病程。该病例说明了OLT后肿瘤生长和进展的高度变异性。这一信息对OLT后复发性HCC长期监测需求的影响仍有待确定。